For my medullary patients the ones with the FDA warning I'm still saying, until we have better data, I can't recommend it
The gap between theoretical synergy and actual measurable outcomes comes down to three variables most protocols ignore: receptor saturation windows, NAD+ depletion kinetics, and the 46 hour offset that allows both compounds to exert their effects without interference
- GHK-Cu is a cGMP capsule research product containing 2MG per capsule with 60 capsules per bottle , providing 120MG total GHK-Cu content
In fact, growth hormone releasing peptides were discovered several years prior, starting with GHRP-6 and GHRP-2, as scientists were particularly interested in their benefits for heart health [14]
See the full list here
For compounded medications, tirzepatide costs about $150/month more ($349 vs $199 at TrimRx)